Caesarean Scar Revision With the UltraPulse

Inclusion criteria

• Females in good general health older than 22 years of age and younger than 55 years of age.
• Presenting with a caesarean scar mature and stable caesarean scar (at least 1 year post procedure).
• At least six months following termination of breast feeding.
• Willing to give and sign an informed consent form and a photographic release form.
• Willing to comply with study dosing and complete the entire course of the study .
• Performed negative pregnancy test.

Exclusion criteria

• Active bacterial, fungal, or viral infection in the treatment area.
• Active cold sores, or herpes in the treatment area.
• Recent excessive exposure to sunlight or artificial UV light (e.g.: use of tanning beds/booths and/or sunbathing) or expectations of tanning during the time of the study .
• History of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis).
• Treatment with a systemic retinoid within the past year (e.g., Accutane®, Roche Dermatologics).
• History or presenting with a keloid scar.
• Any current or recent treatment for cancer.
• Any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study.
• Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
• Previous laser treatments on the same scar at least 0.5 year prior to this evaluation.
• Subject planning any other cosmetic procedure to the study area during the study period, other than the treatments that will be performed by the investigator .
• Any other condition that may exclude patient for treatment per physician discretion.
• Female subject who is pregnant, nursing an infant .